Malaria

Vaccines Against Mosquito Midgut Receptors May Limit Transmission

Published in TB and Outbreaks Week, June 19th, 2001

by N.R. Saltmarsh, staff medical writer - By preventing development of Plasmodium species in mosquitoes, antibodies targeting the mosquito midgut could eventually halt the global transmission of malaria.

"The mosquito midgut plays a central role in the sporogonic development of malaria parasites," explained A.A. Lal and colleagues at the U.S. Centers for Disease Control and Prevention. "We have found that polyclonal sera, produced against mosquito midguts, blocked the passage of P. falciparum ookinetes across the midgut, leading to a significant reduction of infections in mosquitoes."

Lal and associates developed anti-midgut monoclonal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-06-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry